FindTrial
Sign In

Nasal administration of dexmedetomidine in different pediatric populations: a pharmacokinetics study

Nasal administration of dexmedetomidine in different pediatric populations: a pharmacokinetics study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050083
Enrollment
Unknown
Registered
2021-08-16
Start date
2021-08-09
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Nasal drip success group:None
Nasal instillation failure group:None
Nasal drip combined with complications group:None

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. The child is selected to perform MRI examination under sedation; 2. After the assessment by the anesthesiologist, the child agreed to receive dexmedetomidine 2mcg/kg nasally; 3. Children aged 1-6 years; 4. The written consent of the patient's family must be obtained to participate in the experiment.

Exclusion criteria

Exclusion criteria: Patients allergic to dexmedetomidine and midazolam.

Design outcomes

Primary

MeasureTime frame
plasma concentration;—

Secondary

MeasureTime frame
onset time;adverse reaction;—

Countries

China

Contacts

Public ContactShe Yingjun

Guangzhou Women and Children's Medical Center

yjsheh@yeah.net+86 13826012672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026